The process of selecting clinical trial sites and launching studies, beginning with site identification and ending with study start-up completion, takes an average of 31.4 weeks, a full month longer than the average 10 years ago, according to new research from the Tufts Center for the Study of Drug Development.
Source: Drug Industry Daily